Bielenda Neuro Glicol and Vit C Neuromimetic Exfoliating and Rejuvenating Night Serum 30ml
Technologically advanced Neuro Glicol + Vit. C line combines revolutionary properties of Neuropeptide, which blocks neurotransmitters responsible for muscle contraction, leading to a visible smoothing of the skin, with the power of advanced Glicolic Acid and 100% Stable Vitamin C exfoliation. Such formula enables effective protection of the skin against ageing and restores its natural beauty.
Spectacular skin renewal effects are guaranteed by intelligent active ingredients with proven efficacy and precision, which penetrate deeply into the skin and gradually release their power, acting for a long time after application.
100% Stable Vitamin C Forte is one of the strongest antioxidants. It stimulates collagen production, slows down ageing processes, protects DNA, strengthens and regenerates the skin.
Effectively evens out skin tone, reduces pigmentation disorders, reduces the tendency for discolouration and ruptured capillaries, adds glow to the skin, protects against photo- and chronoageing, optimally moisturizes.
High 4.5% concentration of Glycolic Acid improves the condition of skin at any age. It exfoliates the epidermis, stimulating the repair processes of the skin, smooths the skin and evens out its tone.
Tightens the pores, reduces excessive sebum secretion, prevents breakouts.
It increases collagen production, reducing wrinkles, and slows down the ageing process of the skin. Supports renewal and regeneration of the dermis, optimally moisturizes.
Neuropeptide is a modern, new-generation peptide, considered one of the best anti-wrinkle ingredients, because it inhibits contractions of facial muscles responsible for the formation of wrinkles. It effectively prevents formation of new wrinkles and smooths the existing ones.
Application
Every evening , massage the serum into the skin of the face. Avoid eye area.
Capacity: 30ml
Professional Only | No |
---|---|
Manufacturer | Bielenda |
SKU | 5902169025540 |
Expiry Date | 28/04/2027 |